Kiener Peter A 4
4 · Cue Biopharma, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Kiener Peter A
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-02+24,400→ 24,400 totalExercise: $1.09Exp: 2035-01-01→ Common Stock (24,400 underlying)
Footnotes (2)
- [F1]Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- [F2]This option was granted on January 2, 2025. The option is scheduled to vest as to 50% of the underlying shares on the six-month anniversary of the grant date and as to the remaining 50% on the first anniversary of the grant date.